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hydrostatic pressurization of cartilage. The tissue’s ﬁxed negative charge
density is determined by the glycosaminoglycan (GAG) chains in the PGs.
Healthy cartilage has a (physiological) tonicity of 350–480 mOsm, while
the tonicity of the ECM in OA stage-dependently approaches plasma
values (i.e. ~280mOsm). Culturing chondrocytes under tonic conditions
improves their phenotype. Calcineurin inhibition promotes chondrogenic
marker expression and is known to regulate cellular hypertrophy in other
tissues.
We aimed to elucidate if modulating calcineurin activity under
physiological conditions can improve the chondrogenic phenotype while
preventing hypertrophic differentiation of human chondrocytes in vitro.
Methods: Human articular chondrocytes (HACs) were isolated and
cultured in DMEM of 380 and 280mOsm (control) with or without
addition of calcineurin inhibitor FK506 in passage 1 (P1) and
P2. Chondrogenic (COL types -II, -IX, -XI; aggrecan, matrilin 1),
(pre-)hypertrophic (Ihh, COL-X, MMP-13; alkaline phosphatase, ALP;
VEGF), catabolic (MMPs, ADAMTS’) and osteogenic (COL-I, Runx2, SPP-1)
markers were evaluated on mRNA and protein level in 2D monolayer
cultures and 3D microtissues. Treatment was also evaluated employing
non-arthritic chondrocytes and cartilage explants as was the contribution
of TGFb/BMP signaling.
Results: Compared to the 280mOsm control, culturing HACs at
physiological tonicity (380mOsm) showed a general beneﬁcial trend
in chondrogenic marker expression, with increased mRNA levels of
COL2, AGC and SOX9 and suppression of unwanted COL1. Inhibiting
calcineurin activity using FK506 further improved the anabolic effects of
physiological tonicity (e.g. COL2 50-fold, n = 6; veriﬁed on protein level in
2D and 3D), but decreased tonicity-induced expression of collagenases
and aggrecanases. The tonicity-induced expression of hypertrophy
markers COL-X, MMP-13 and ALPL was selectively, dose-dependently
inhibited by FK506 (n =6), which also reduced ALPL and MMP13 activity.
Similar effects were found in non-arthritic chondrocytes and cartilage
explants (n = 3 patients ea.). TGFb superfamily members were selectively
up-regulated by tonicity, while FK506 seems to antagonize BMP-induced
hypertrophic differentiation.
Conclusions: Physiological tonicity largely improves chondrogenic
marker expression in primary human chondrocytes in vitro, but
up-regulates several hypertrophic markers. Under these conditions,
inhibition of calcineurin activity selectively suppresses catabolic and
hypertrophic markers, which is at least partially mediated by TGFb
superfamily signaling. Our ﬁnding may open new venues in the
treatment of OA.
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COUNTER-REGULATION OF CHONDROCYTE MATRIX HOMEOSTASIS BY
OPPOSING ACTIVITIES OF LKB1 PROTEIN KINASE AND PP2C PROTEIN
PHOSPHATASE
R. Terkeltaub1, B. Yang1, M. Lotz2, R. Liu-Bryan1. 1VAMC Med.-
Rheumatology, UCSD, San Diego, CA, USA; 2The Scripps Res. Inst., La Jolla,
CA, USA
Purpose: AMP-activated protein kinase (AMPK) is a super-regulator
of energy homeostasis and cellular metabolism, and increases muscle
stamina. In addition, AMPK suppresses inﬂammation, partly by inhibiting
NF-úB activation. Recently, reduced AMPK activity was discovered to
develop in human knee OA chondrocytes and in cultured chondrocytes
treated with the inﬂammatory cytokines IL-1b and TNFa. AMPK activators
suppress cartilage matrix degradation induced by IL-1b and TNFa in
vitro. LKB1 is the major upstream activating kinase of AMPK, and
PP2C is a protein phosphatase that can dephosphorylate AMPKa.
Here, we examined the roles of LKB1 and PP2C in regulation of
AMPK in articular chondrocytes. SIRT1, a NAD-dependent histone/protein
deacetylase, is another nutrient-sensing metabolic regulator. Decreased
SIRT1 expression is observed in human OA cartilage, and SIRT1 activity
is shown to be chondroprotective in vitro. Since SIRT1 has been
demonstrated to modulate LKB1, we also tested if SIRT1 regulates AMPK
activity in articular chondrocytes.
Methods: Expression and phosphorylation of LKB1 were examined in
human knee cartilage sections from different donors without (grade
I) and with OA (grades II-IV). We also studied normal aging mouse
knee cartilage sections (with an age range of 3, 6, 12 and 24 months).
Expression of PP2C was assessed in normal articular chondrocytes in
response to IL-1b and TNFa. LKB1 and SIRT1 were either overexpressed
or knocked down in human chondrocytes via transfection with their
cDNAs and siRNAs, respectively. Resveratrol was used to active Sirt1.
Status of acetylation of LKB1, phosphorylation of LKB1 and AMPKa were
examined, and we assayed pro-catabolic responses including nitric oxide
(NO) generation, and expression of MMP-3 in response to IL-1b and
TNFa.
Results: Decreased expression and phosphorylation of LKB1, and
concurrently AMPKa, were observed in human knee OA cartilages
compared with normal cartilage. In addition, there was age-related
loss of expression and phosphorylation of LKB1 in the aging
mouse knee cartilages. IL-1b and TNFa induced PP2Ca expression
in chondrocytes. Knockdown of LKB1 in chondrocytes resulted in
attenuated phosphorylation of AMPKa and increased NO generation (by
50% and 80%, respectively, P < 0.05) and augmented MMP-3 release in
response to IL-1b and TNFa. Activation of SIRT1 by resveratrol resulted
in de-acetylation of LKB1 and increased phosphorylation (activation
responses) of both LKB1 and AMPKa. Overexpression of SIRT1 and LKB1
increased phosphorylation of LKB1, and prevented de-phosphorylation
of AMPKa induced by IL-1b and TNFa. Last, knockdown of SIRT1 led
to decreased phosphorylation of AMPKa and increased chondrocyte
catabolic responses to IL-1b and TNFa.
Conclusions: AMPK activity is promoted by LKB1 and inhibited by PP2C
in articular chondrocytes. SIRT1 plays a central role in this functional
loop by activating AMPK, mediated by SIRT1-induced LKB1 activation in
chondrocytes. Maintenance of AMPK activity by stimulation of the LKB1
and/or inhibition of PP2C in articular chondrocytes has novel therapeutic
potential to prevent cartilage matrix degradation, and thereby to slow
progression of OA.
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OSTEOARTHRITIC ARTICULAR CARTILAGE EXPRESSES THE PTH
RECEPTOR; PTH EFFECTS CARTILAGE METABOLISM
B-C. Sondergaard1, I.J. Klausen1, N.A. Sims2, R.H. Nielsen1, J.H. Gooi2,
M.A. Karsdal1, A-C. Bay-Jensen1. 1Nordic BioSci., Herlev, Denmark; 2St.
Vincent’s Inst., Fitzroy, Australia
Purpose: The pathogenesis of osteoarthritis (OA) affects both the bone
and cartilage compartment. Parathyroid hormone (PTH) is a well-known
modulator of calcium homeostasis and exerts both anabolic and catabolic
effects on bone related to treatment of osteoporosis. PTH acts on
osteoblasts, initiating the G-coupled receptor pathway through cAMP.
Recently, cAMP has been shown to be of major importance for the
chondrocyte phenotype. We set out to investigate the effect of PTH in
relation to OA. The expression of PTH receptor 1 (PTH1R) and the effects
of PTH on human osteoarthritic cartilage were investigated in vitro. The
effect on cartilage degradation was investigated in a rodent model of
accelerated bone and cartilage loss.
Methods: In vitro: The expression of the PTH1R was investigated
in human OA chondrocytes by qPCR, the PTH1R protein by
immunohistochemistry (IHC) in full thickness cartilage explants, and
functionality by cAMP ELISA. Human OA chondrocytes were isolated by
enzyme treatment and subsequently maintained serum-free for 1 hour
in the presence of 100mM IBMX (a phosphordiesterase inhibitor), and
subsequently stimulated with PTH(1–84) 1 nM-100nM + IBMX for 30
min and the intracellular levels of cAMP were quantiﬁed by ELISA.
Direct anabolic effects of PTH were studied in vitro by stimulation of
human OA articular cartilage explants with doses of 1 nM-100 mM
PTH. The cultures were maintained for 17 days and pulsed by 5mCi
35Sulphate. Anabolic effects on proteoglycan formation were evaluated by
incorporation of 35Sulphate, followed by liquid scintillation counting in
the extracted cartilage proteoglycan. Effects on collagen type II formation
were investigated in the conditioned medium from the explants cultures
by quantiﬁcation of neo-epitopes of the N-terminal propeptide of
collagen type II by ELISA (PIINP). In vivo: Thirty 5-month old female rats
were subjected to either sham or ovariectomy (OVX), and administered
either vehicle or 30mg/kg hPTH (1–34) by s.c. injection for 5 weeks,
n = 10. Serum levels of osteocalcin and collagen type II degradation neo-
epitopes (CTX-II) were measured by ELISA.
Results: Human articular chondrocytes expressed the PTH receptor
1 as detected by qPCR and IHC. PTH stimulation induced increased
levels of intracellular cAMP (P < 0.003) compared with vehicle control.
Additionally, PTH increased the release of PIINP from OA articular
cartilage explants cultures by two-fold. Furthermore, 10nM PTH
increased incorporation of 35sulphate by 40% (P = 0.002). In the in vivo
study of rodents subjected to OVX and treated by s.c injections of PTH, the
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serum level of the bone turnover marker osteocalcin was signiﬁcantly
(P < 0.001) elevated in OVX and PTH treated compared to sham and
vehicle treated, while the collagen type II degradation decreased, as the
level of serum cartilage degradation marker CTX-II was reduced by 30%
(P < 0.01), compared to vehicle treated OVX animals.
Conclusions: Human OA chondrocytes express the PTH1R receptor
and PTH seems to induce an anabolic response in articular cartilage.
Moreover, PTH had an anti-catabolic effect in the preclinical model of
accelerated cartilage loss. Current results strongly suggest that PTH has
direct beneﬁcial effects on human OA chondrocytes and cartilage. Further
research is necessary to investigate the potential of PTH as a disease
modifying OA drug (DMOAD).
256
EFFECT OF DIACEREIN/RHEIN ON THE WNT SYSTEM IN HUMAN
OSTEOARTHRITIC SUBCHONDRAL BONE
J. Martel-Pelletier, F. Mineau, J. Caron, J-P. Pelletier. Univ. of Montreal
Hosp. Res. Ctr. (CRCHUM), Montreal, QC, Canada
Purpose: The alterations in subchondral bone are an essential component
of the structural changes that occur in osteoarthritis (OA). These include
the undermineralization of the OA subchondral bone matrix, which is
related to a signiﬁcant increase in collagen type I alpha 1 (COL1A1).
Previous studies have demonstrated that diacerein, an antirheumatic
drug from the anthraquinone chemical class, improves OA subchondral
bone metabolism and has a potential role in promoting homeostasis of
this tissue in OA patients. The aim of the present study was to further
investigate whether the mode of action of diacerein on OA subchondral
bone could be mediated through an action on the Wnt system, more
speciﬁcally on the canonical pathway b-catenin, the Wnt-1-induced
secreted protein 1 (WISP-1), and the Wnt antagonists dickkopf (DKK)-1
and DKK-2. Moreover, we also studied the effect of diacerein on the level
of COL1A1 and COL1A2.
Methods: Normal and OA human subchondral bone osteoblast basal
expression levels (real time PCR) of b-catenin, WISP-1, DKK-1 and DKK-2
were evaluated. OA osteoblasts were cultured in a medium containing 5,
10 or 20mg/ml diacerein and rhein (the active metabolite of diacerein)
for 18 h, and the expression levels of the above factors as well as COL1A1
and COL1A2 were evaluated.
Results: The expression levels of b-catenin and WISP-1 were similar
in normal and OA subchondral bone osteoblasts, whereas DKK-1 and
DKK-2 were signiﬁcantly increased (p≤0.05) in OA cells. Treatment with
diacerein/rhein signiﬁcantly reduced the expression level of COL1A1
at concentrations of 10 and 20mg/ml (p≤0.004), whereas the level of
COL1A2 remained unchanged. Interestingly, the ratio of COL1A1-to-
COL1A2 decreased dose-dependently in diacerein treated cells. Moreover,
the drugs signiﬁcantly elevated the expression level of b-catenin (p≤0.01)
and dose-dependently inhibited the Wnt antagonists DKK-1 and DKK-2
(p≤0.009). The WISP expression level was increased by diacerein/rhein
at all concentrations tested.
Conclusion: These ﬁndings indicate that treatment with diacerein has
a positive impact on OA subchondral bone osteoblasts by increasing the
level of b-catenin, decreasing the levels of major inhibitors of the Wnt
system, and curbing collagen type I formation, which, if translated in
vivo, will have a potentially beneﬁcial effect on mineralization of this OA
tissue.
This study was funded in part by a grant from TRB Chemedica
International S.A., Geneva, Switzerland.
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ANALYSIS OF AUTOPHAGIC ACTIVITY IN HUMAN CARTILAGE AND
CHONDROCYTES
H. Sasaki, T. Matsushita, K. Takayama, S. Kubo, T. Matsumoto, K. Ishida,
S. Oka, M. Kurosaka, R. Kuroda. Kobe Univ. Graduate Sch. of Med., Kobe,
Japan
Purpose: Autophagy, an evolutionarily conserved process for the bulk
degradation of cytoplasmic components, has been reported to be a
cell survival mechanism under starved conditions. The main functions
of autophagy are housekeeping and quality control of proteins and
organelles, therefore dysfunction of autophagy has been indicated as
a cause of some degenerative diseases. However the role of autophagy
in osteoarthritis (OA), the most common degenerative disease in human
joints, has not yet been clear. The purpose of this study is to analyze
autophagic activity in human chondrocytes and pathophysiology of OA.
Materials and Methods: OA articular cartilage was obtained from
femoral condyles of patients with medial type OA during total knee
arthroplasty. Lateral condyles and medial condyles were used as mild OA
cartilage and severe OA cartilage respectively. Human non-OA cartilage
was obtained from femoral heads of patients with femoral neck fracture
and used as non-OA cartilage. Primary chondrocytes were also isolated
from the articular cartilage samples of patients with OA and used as OA
chondrocytes. Normal Human Articular Chondrocytes-knee (NHAC-kn)
cells were purchased and used as normal human chondrocytes. The state
of autophagy in the articular cartilage samples and the chondrocytes
were assessed by immunohistochemistry and immunoblotting using
antibodies for autophagy markers, LC3II and beclin1. In addition, we
stimulated NHAC-kn cells with various stresses (IL-1b, NO, serum
starvation) and examined the effects of the stresses on the autophagic
activity by real-time PCR and immunoblotting.
Results: Immunohistochemical analysis showed that the expression of
LC3 and beclin-1 were increased in the mild OA cartilage compared with
the non-OA cartilage. On the other hand, the expression of LC3 and
beclin-1 were decreased in the severe cartilage. LC3 and beclin1 were
more strongly expressed in the superﬁcial zone of the mild OA cartilage
than in the deep zone and the middle zone. In addition, the primary
OA chondrocytes strongly expressed LC3II and beclin-1 compared with
NHAC-kn. Furthermore the expression of LC3 and beclin-1 in NHAC-kn
were increased by the stresses.
Conclusions: In this study, we found that autophagy was increased
in the mild OA cartilage. Autophagy was especially increased in the
superﬁcial zone presumably where chondrocytes were under more
stresses compared with other zones. In addition, autophagy was
increased in normal chondrocytes by the stresses in vitro. These
observations suggested autophagic activity increases during early stage
of OA and the increased autophagy was an adaptive response to protect
cells from stresses. On the other hand, autophagy was decreased in
the severe OA cartilage, suggesting that dysfunction of autophagy might
be a cause of the progression of OA. Further studies about autophagy
in chondrocytes will provide novel insights into the pathophysiology
of OA.
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EFFECT OF MECHANICAL STRESS OR ITS COMBINATION WITH MAPK
INHIBITOR ON THE CHONDROCYTIC PHENOTYPE OF 3-DIMENSIONAL
SCAFFOLD-EMBEDDED RAT CHONDROCYTES
S. Shioji. Shiga Univ. of Med. Sci., Otsu, Japan
Purpose: Chondrocytes play the major role in the homeostasis of
articular cartilage, and they alter the activity of matrix synthesis in
response to mechanical stress (MS).
A variety of signaling pathways have been implicated in the
signaling process following the mechanical activation of chondrocytes.
The signaling pathways related to mechanotransduction have
been demonstrated to use the mitogen activated protein kinases
(MAPKs) pathway, in which extracellular-regulated kinase (ERK), c-Jun
N-terminal kinase (JNK) and p38 constitute the signaling kinase. The
mechanotransduction roles of ERK, JNK, and p38 pathway have remained
controversial.
Since chondrocytes alter their metabolic activities according to their
extracellular environments, we studied signaling pathways also using
3-dimensional (3D)-embedded chondrocytes. The present study attempts
to characterize their responses to mechanical stress in terms of the
extracellular and intracellular pathways of mechanotransduction.
Methods: Chondrocytes were isolated from rat articular cartilage. On
reaching conﬂuence, the cells were 3D-embedded in type 1 collagen
scaffold. The cell-seeded scaffold was cultured either under mechanical
stress (MS group). To investigate the involvement of second messenger
pathway(s) of ERK, JNK and p38, the 3D-embedded chondrocytes
were incubated in the presence or absence of the ERK inhibitor
UO126, the JNK inhibitor SP600125, or the p38 inhibitor SB203580 at
different concentration prior to MS. The mechanical stress was a cyclic
compression at 5% compression, 0.33Hz for 1hours. The 3D-embedded
chondrocytes with neither mechanical stress nor MAPK inhibitor served
as non-stressed (NS) cells. Real-time PCR was performed for Aggrecan
(AGC), type 2 collagen (Col.2), and GAPDH at 1hour after the application
of the mechanical stress.
Results: Expression of AGC and Col.2 was signiﬁcantly upregulated in MS
group when compared with that of the NS group. We then found that the
